VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,141 | -10.6% | 11,265 | 0.0% | 0.10% | -12.1% |
| Q2 2023 | $339,189 | -6.9% | 11,265 | 0.0% | 0.12% | -7.9% |
| Q1 2023 | $364,423 | +12.9% | 11,265 | 0.0% | 0.13% | +5.0% |
| Q4 2022 | $322,855 | +18.7% | 11,265 | 0.0% | 0.12% | +5.3% |
| Q3 2022 | $272,000 | -11.7% | 11,265 | 0.0% | 0.11% | -3.4% |
| Q2 2022 | $308,000 | -28.7% | 11,265 | 0.0% | 0.12% | -11.3% |
| Q1 2022 | $432,000 | +25.6% | 11,265 | 0.0% | 0.13% | +26.7% |
| Q4 2021 | $344,000 | +2.7% | 11,265 | 0.0% | 0.10% | -3.7% |
| Q3 2021 | $335,000 | -12.5% | 11,265 | 0.0% | 0.11% | -14.2% |
| Q2 2021 | $383,000 | +4.6% | 11,265 | 0.0% | 0.13% | -11.8% |
| Q1 2021 | $366,000 | -9.9% | 11,265 | 0.0% | 0.14% | -10.6% |
| Q4 2020 | $406,000 | -11.5% | 11,265 | 0.0% | 0.16% | -26.1% |
| Q3 2020 | $459,000 | +6.0% | 11,265 | 0.0% | 0.22% | +9.0% |
| Q2 2020 | $433,000 | +28.5% | 11,265 | 0.0% | 0.20% | +7.0% |
| Q1 2020 | $337,000 | +2.1% | 11,265 | 0.0% | 0.19% | +19.1% |
| Q4 2019 | $330,000 | +9.6% | 11,265 | 0.0% | 0.16% | +5.4% |
| Q3 2019 | $301,000 | +4.9% | 11,265 | 0.0% | 0.15% | -2.6% |
| Q2 2019 | $287,000 | +13.9% | 11,265 | 0.0% | 0.15% | +10.1% |
| Q1 2019 | $252,000 | +6.3% | 11,265 | 0.0% | 0.14% | -7.3% |
| Q4 2018 | $237,000 | +13.9% | 11,265 | 0.0% | 0.15% | +44.2% |
| Q3 2018 | $208,000 | -17.1% | 11,265 | 0.0% | 0.10% | -28.3% |
| Q2 2018 | $251,000 | +1.6% | 11,265 | 0.0% | 0.14% | +1.4% |
| Q1 2018 | $247,000 | -5.4% | 11,265 | 0.0% | 0.14% | -4.0% |
| Q4 2017 | $261,000 | +2272.7% | 11,265 | +2153.0% | 0.15% | +2028.6% |
| Q3 2017 | $11,000 | 0.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $11,000 | -99.9% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $11,405,000 | +9.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $10,460,000 | -20.8% | 500 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $13,215,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |